Updates Archives - Page 2 of 2 - Desmoid Tumor Research Foundation
Menu

Clinical Trials for Immunotherapy & HIFU

Clinical Trial:  Phase II DART Immunotherapy Despite their name, rare cancers make up more than 20 percent of cancers diagnosed worldwide. DART is a clinical trial testing new treatments for dozens of rare cancers. Desmoid tumor is one of the tumor types included in this trial. The two drugs under study are new FDA-approved immunotherapies. […]

read more

Upcoming Clinical Trials

Phase III Trial for Nirogacestat A new company named SpringWorks Therapeutics has been formed as a spinoff of Pfizer to focus on investigational therapies that hold  significant promise for underserved populations.  SpringWorks will now take the gamma-secretase inhibitor that showed promising results in treating desmoid tumors in Phase I and Phase II trials, into a Phase III trial. Formerly known […]

read more
Showing 11 to 12 of 12 results
  TOP